ArticleEuropean heart journal open2024

Health-related quality of life with rivaroxaban plus aspirin vs. aspirin alone in chronic stable cardiovascular disease: Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) trial.

Feng Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.